Bevacizumab versus ranibizumab for AMD

N Engl J Med. 2011 May 19;364(20):1966-7. doi: 10.1056/NEJMe1103334. Epub 2011 Apr 28.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Drug Administration Schedule
  • Humans
  • Macular Degeneration / drug therapy*
  • Ranibizumab
  • Therapeutic Equivalency

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Ranibizumab